Here, in SM‐resistant ALL cells, cIAP‐1 was consistently degraded by the SM‐drug combination (Appendix Fig S1M) but also by treatment with SM alone (Appendix Fig S1N), indicating that cIAP‐1 degradation is not sufficient to induce cell death. Here, BIRC2 is linked to acute lymphoblastic leukemia.